Legal & General Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.28M Sell
225,560
-6,572
-3% -$119K ﹤0.01% 1476
2025
Q4
$3.29M Sell
232,132
-12,541
-5% -$237K ﹤0.01% 1776
2025
Q3
$6.06M Buy
244,673
+92,506
+61% +$2.06M ﹤0.01% 1465
2025
Q2
$3.45M Buy
152,167
+5,807
+4% +$138K ﹤0.01% 1725
2025
Q1
$4.44M Buy
146,360
+4,765
+3% +$182K ﹤0.01% 1588
2024
Q4
$5.61M Sell
141,595
-589
-0.4% -$26.6K ﹤0.01% 1522
2024
Q3
$9.02M Buy
142,184
+2,591
+2% +$187K ﹤0.01% 1238
2024
Q2
$9.43M Buy
139,593
+897
+0.6% +$62.6K ﹤0.01% 1157
2024
Q1
$11M Buy
138,696
+2,462
+2% +$201K ﹤0.01% 1091
2023
Q4
$10.6M Sell
136,234
-3,569
-3% -$264K ﹤0.01% 1103
2023
Q3
$9.83M Sell
139,803
-1,510
-1% -$113K ﹤0.01% 1087
2023
Q2
$11.3M Buy
141,313
+3,019
+2% +$218K ﹤0.01% 1049
2023
Q1
$9.99M Buy
138,294
+3,942
+3% +$307K ﹤0.01% 1064
2022
Q4
$11.1M Buy
134,352
+4,783
+4% +$394K ﹤0.01% 1025
2022
Q3
$10.1M Sell
129,569
-4,569
-3% -$365K ﹤0.01% 1024
2022
Q2
$9.07M Buy
134,138
+1,610
+1% +$112K ﹤0.01% 1111
2022
Q1
$8.69M Sell
132,528
-928
-0.7% -$53.9K ﹤0.01% 1228
2021
Q4
$8.1M Buy
133,456
+5,480
+4% +$327K ﹤0.01% 1313
2021
Q3
$8.16M Sell
127,976
-6,815
-5% -$430K ﹤0.01% 1275
2021
Q2
$8.46M Sell
134,791
-21,220
-14% -$1.33M ﹤0.01% 1260
2021
Q1
$8.91M Buy
156,011
+4,170
+3% +$226K ﹤0.01% 1270
2020
Q4
$7.63M Sell
151,841
-19,878
-12% -$792K ﹤0.01% 1260
2020
Q3
$5.06M Buy
171,719
+6,442
+4% +$187K ﹤0.01% 1321
2020
Q2
$4.15M Buy
165,277
+29,308
+22% +$732K ﹤0.01% 1401
2020
Q1
$2.5M Sell
135,969
-88
-0.1% -$2.52K ﹤0.01% 1478
2019
Q4
$4.52M Buy
136,057
+1,613
+1% +$50.5K ﹤0.01% 1420
2019
Q3
$4.18M Buy
134,444
+8,619
+7% +$262K ﹤0.01% 1385
2019
Q2
$4.4M Buy
125,825
+1,146
+0.9% +$37K ﹤0.01% 1337
2019
Q1
$3.65M Buy
124,679
+12,011
+11% +$340K ﹤0.01% 1385
2018
Q4
$2.9M Buy
112,668
+4,426
+4% +$153K ﹤0.01% 1383
2018
Q3
$3.81M Buy
108,242
+10,933
+11% +$436K ﹤0.01% 1353
2018
Q2
$3.98M Buy
97,309
+3,868
+4% +$156K ﹤0.01% 1268
2018
Q1
$3.66M Buy
93,441
+16,126
+21% +$591K ﹤0.01% 1273
2017
Q4
$2.52M Buy
77,315
+8,675
+13% +$301K ﹤0.01% 1494
2017
Q3
$3.28M Buy
68,640
+9,205
+15% +$449K ﹤0.01% 1283
2017
Q2
$2.93M Buy
59,435
+33,679
+131% +$1.49M ﹤0.01% 1297
2017
Q1
$1.12M Buy
25,756
+17,865
+226% +$725K ﹤0.01% 1754
2016
Q4
$261K Buy
7,891
+879
+13% +$34.1K ﹤0.01% 2151
2016
Q3
$348K Buy
7,012
+1,646
+31% +$85.7K ﹤0.01% 1864
2016
Q2
$297K Buy
5,366
+302
+6% +$17.7K ﹤0.01% 1612
2016
Q1
$279K Buy
5,064
+1,986
+65% +$113K ﹤0.01% 1606
2015
Q4
$192K Buy
3,078
+272
+10% +$17.7K ﹤0.01% 1763
2015
Q3
$186K Buy
2,806
+739
+36% +$56.8K ﹤0.01% 1742
2015
Q2
$162K Sell
2,067
-5,924
-74% -$426K ﹤0.01% 1837
2015
Q1
$572K Buy
7,991
+1,475
+23% +$94.6K ﹤0.01% 1250
2014
Q4
$407K Buy
6,516
+1,251
+24% +$72.8K ﹤0.01% 1298
2014
Q3
$259K Buy
+5,265
New +$257K ﹤0.01% 1383

Other funds holding ACHC

Legal & General Group's ACHC Position: Q1 2026 in Review

Legal & General Group reduced its Acadia Healthcare (ACHC) stake by 2.8% in Q1 2026, selling an estimated $119K and leaving 225,560 shares worth $5.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

Legal & General Group first reported a position in ACHC in Q3 2014 and has held it in 47 quarters since. The position peaked at $11.3M in Q2 2023. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Legal & General Group held 225,560 shares of Acadia Healthcare worth $5.28M as of Q1 2026.
  • Legal & General Group sold 6,572 Acadia Healthcare shares in Q1 2026, an estimated $119K.
  • Acadia Healthcare made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1476 holding.
  • Legal & General Group first reported a position in Acadia Healthcare in Q3 2014 and has held it in 47 quarters since.
  • Legal & General Group's Acadia Healthcare position peaked at $11.3M in Q2 2023.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.